• 1. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An ionic liquid-based synergistic extraction strategy for rare earths?
  Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993
• 4. An easier analysis of complex mixtures with highly resolved and sensitivity enhanced 2D quantitative NMR: application to tracking sugar phosphates in plants?
  Soumaya Khlifi,Gregory Mouille,Jonathan Farjon Anal. Methods, 2017,9, 2328-2333
• 5. An automated in-chip-catalytic–spectrophotometric method for determination of copper(ii) using a multisyringe flow injection analysis-multipumping flow system?
  Camelia Henríquez,Edwin Palacio,Víctor Cerdà Anal. Methods, 2014,6, 8494-8504

Introduction to 4,7-Dimethoxy-1H-Benzimidazole-2-Methanol (CAS No. 103151-22-0)

4,7-Dimethoxy-1H-Benzimidazole-2-methanol (CAS No. 103151-22-0) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique molecular structure, exhibits a range of biological activities that make it a valuable candidate for various therapeutic applications.

The chemical structure of 4,7-Dimethoxy-1H-Benzimidazole-2-Methanol consists of a benzimidazole core with methoxy substituents at the 4 and 7 positions, and a hydroxymethyl group at the 2 position. This specific arrangement of functional groups imparts distinct chemical and biological properties to the molecule. The benzimidazole scaffold is well-known for its ability to interact with various biological targets, including enzymes, receptors, and nucleic acids, making it a common motif in drug design.

Recent studies have highlighted the potential of 4,7-Dimoxy-1H-Benzimidazole-2-Methanol in several therapeutic areas. One notable application is its use as an antifungal agent. Research published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits potent antifungal activity against a variety of pathogenic fungi, including Candida albicans and Aspergillus fumigatus. The mechanism of action involves the disruption of fungal cell wall synthesis and membrane integrity, leading to cell death.

In addition to its antifungal properties, 4,7-Dimethoxy-1H-Benzimidazole-2-Methanol has shown promise as an anticancer agent. Preclinical studies have reported that this compound can inhibit the growth of various cancer cell lines, including those derived from breast, lung, and colon cancers. The anticancer activity is attributed to its ability to induce apoptosis and cell cycle arrest through the modulation of key signaling pathways such as p53 and Bcl-2.

The pharmacokinetic profile of 4,7-Dimethoxy-1H-Benzimidazole-2-Methanol has also been investigated. Studies have shown that it has favorable oral bioavailability and a reasonable half-life in vivo, which are important considerations for its potential development as an oral therapeutic agent. Furthermore, the compound has demonstrated low toxicity in preclinical models, suggesting a favorable safety profile.

In terms of synthetic accessibility, 4,7-Dimethoxy-1H-Benzimidazole-2-Methanol can be synthesized through several well-established routes. One common approach involves the condensation of 4,7-dimethoxybenzimidazole with formaldehyde followed by reduction to form the hydroxymethyl derivative. This synthetic route is scalable and can be adapted for large-scale production if needed.

The potential applications of 4,7-Dimethoxy-1H-Benzimidazole-2-Methanol extend beyond antifungal and anticancer therapies. Recent research has explored its use as a neuroprotective agent in neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Studies have shown that this compound can reduce oxidative stress and inflammation in neuronal cells, thereby protecting against neurodegeneration.

In conclusion, 4,7-Dimethoxy-1H-Benzimidazole-2-Methanol (CAS No. 103151-22-0) is a promising compound with a wide range of biological activities and therapeutic potential. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for further development in various medical applications. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical uses.

• 20033-99-2((5-methoxy-1H-benzimidazol-2-yl)methanol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)